Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 677,955 |
|
|||||
| News | (2) | ||||||
| Day High | 10.37 | Low High |
|||||
| Day Low | 9.55 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Astria Therapeutics Inc | ATXS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.60 | 6.27% | 10.17 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 9.61 | 9.55 | 10.37 | 10.17 | 9.57 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,476 | 677,955 | $ 10.16 | $ 6,889,891 | - | 4.26 - 16.90 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:24:26 | 10 | $ 10.42 | USD |
Astria Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 468.87M | 54.90M | - | 0 | -72.89M | -1.33 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Astria Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATXS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 9.61 | 10.37 | 9.21 | 9.60 | 578,434 | 0.56 | 5.83% |
| 1 Month | 11.22 | 11.62 | 8.81 | 9.73 | 833,293 | -1.05 | -9.36% |
| 3 Months | 14.10 | 16.90 | 8.81 | 13.03 | 1,050,009 | -3.93 | -27.87% |
| 6 Months | 4.74 | 16.90 | 4.26 | 11.29 | 842,387 | 5.43 | 114.56% |
| 1 Year | 12.50 | 16.90 | 4.26 | 10.72 | 529,473 | -2.33 | -18.64% |
| 3 Years | 8.53 | 16.90 | 2.36 | 10.42 | 273,685 | 1.64 | 19.23% |
| 5 Years | 8.53 | 16.90 | 2.36 | 10.42 | 273,685 | 1.64 | 19.23% |
Astria Therapeutics Description
| Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. |
